Drug Safety & Medicine Alerts FDA approves AbbVie’s Juvmo for Parkinson’s Disease Once-daily tavapadon approved as monotherapy and adjunctive treatment Sreedevi N R Oct 02, 2026
News PocDoc, IQVIA join hands to improve cardiovascular risk screening PocDoc is building the digital infrastructure for cardiovascular disease prevention, enabling testing to move beyond traditional healthcare settings Shajil Kumar Sep 24, 2026
News Travellers reminded to take precautions to avoid infectious disease Data reveals cases of imported dengue and Zika virus disease in the UK following visits overseas. Sreedevi N R Jul 16, 2026
News CCA calls for a greater role for pharmacies in heart health plan The Cardiovascular Disease Modern Service Framework aims to reduce premature deaths from cardiovascular disease by 25 percent over the next decade Shajil Kumar Jul 09, 2026
News UK formally joins rare disease research partnership Membership in world’s largest alliance opens vital clinical trial pathways for 3.5 million British patients Sreedevi N R Jul 07, 2026
News MHRA consults on framework for rare diseases There are a smaller number of approved medicinal treatments even when rare diseases affect more than 3.5 million people in the UK Sreedevi N R May 21, 2026
News New Alzheimer’s research shows promise: Expert Researchers are moving beyond its long-standing focus on amyloid, a protein central to Alzheimer’s disease Lakshmi Prabha May 07, 2026
Drug Safety & Medicine Alerts New tablet approved to treat biliary tract disease-related itch GlaxoSmithKline‘s Linerixibat (Lynavoy) tablets are approved to treat the itching caused by primary biliary cholangitis (PBC) in adults Lakshmi Prabha May 03, 2026
